Citigroup’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
39,742
+20,558
| +107% | +$205K | ﹤0.01% | 3057 |
|
|
2025
Q1 | $115K | Sell |
19,184
-834,597
| -98% | -$4.98M | ﹤0.01% | 3754 |
|
|
2024
Q4 | $6.56M | Buy |
853,781
+833,589
| +4,128% | +$6.4M | ﹤0.01% | 1220 |
|
|
2024
Q3 | $206K | Buy |
20,192
+8,497
| +73% | +$86.8K | ﹤0.01% | 3564 |
|
|
2024
Q2 | $174K | Sell |
11,695
-284,289
| -96% | -$4.22M | ﹤0.01% | 3245 |
|
|
2024
Q1 | $4.04M | Sell |
295,984
-48,818
| -14% | -$666K | ﹤0.01% | 1373 |
|
|
2023
Q4 | $3.78M | Buy |
344,802
+258,468
| +299% | +$2.83M | ﹤0.01% | 1274 |
|
|
2023
Q3 | $945K | Sell |
86,334
-148,333
| -63% | -$1.62M | ﹤0.01% | 1960 |
|
|
2023
Q2 | $3.11M | Sell |
234,667
-54,218
| -19% | -$718K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $3.93M | Buy |
288,885
+54,589
| +23% | +$743K | ﹤0.01% | 1218 |
|
|
2022
Q4 | $4.58M | Sell |
234,296
-59,957
| -20% | -$1.17M | ﹤0.01% | 1098 |
|
|
2022
Q3 | $5.61M | Buy |
294,253
+168,551
| +134% | +$3.21M | ﹤0.01% | 1064 |
|
|
2022
Q2 | $2.59M | Buy |
125,702
+93,349
| +289% | +$1.92M | ﹤0.01% | 1429 |
|
|
2022
Q1 | $1.04M | Sell |
32,353
-176,147
| -84% | -$5.67M | ﹤0.01% | 2301 |
|
|
2021
Q4 | $9.71M | Sell |
208,500
-204,972
| -50% | -$9.54M | 0.01% | 944 |
|
|
2021
Q3 | $11.2M | Sell |
413,472
-19,012
| -4% | -$513K | 0.01% | 938 |
|
|
2021
Q2 | $11.1M | Buy |
432,484
+397,181
| +1,125% | +$10.2M | 0.01% | 999 |
|
|
2021
Q1 | $1.21M | Buy |
35,303
+31,999
| +968% | +$1.09M | ﹤0.01% | 2251 |
|
|
2020
Q4 | $112K | Buy |
3,304
+2,791
| +544% | +$94.6K | ﹤0.01% | 3608 |
|
|
2020
Q3 | $13K | Buy |
+513
| New | +$13K | ﹤0.01% | 4172 |
|